LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Search

Illumina Inc

Closed

Sector Healthcare

149.8 3.92

Overview

Share price change

24h

Current

Min

147.95

Max

149.85

Key metrics

By Trading Economics

Income

-1.9B

-2B

Sales

30M

1.1B

EPS

0.36

Profit margin

-179.099

Employees

10,590

EBITDA

-1.9B

-1.9B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+5.09 upside

Dividends

By Dow Jones

Next Earnings

4 Nov 2024

Market Stats

By TradingEconomics

Market Cap

478M

23B

Previous open

145.88

Previous close

149.8

News Sentiment

By Acuity

36%

64%

122 / 390 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Illumina Inc Chart

Past performance is not a reliable indicator of future results.

Related News

11 Dec 2023, 18:43 UTC

Acquisitions, Mergers, Takeovers

Illumina Submits SEC Form For Grail Divestiture

5 Mar 2024, 08:00 UTC

Earnings

Earnings Season Is Wrapping Up. Who Came Out Ahead, in 6 Charts. -- Barrons.com

18 Dec 2023, 23:17 UTC

Acquisitions, Mergers, Takeovers

Antitrust Regulators Issue New Merger Rules Amid Crackdown -- Barrons.com

18 Dec 2023, 20:33 UTC

Acquisitions, Mergers, Takeovers

Adobe-Figma Breakup Isn't Just a Win for Regulators. Why Consumers Should Be Cheering Too. -- Barrons.com

18 Dec 2023, 09:48 UTC

Acquisitions, Mergers, Takeovers

Illumina to Sell Grail. It's Giving Up on its Biotech Antitrust Battle. -- Barrons.com

18 Dec 2023, 09:34 UTC

Acquisitions, Mergers, Takeovers

These Stocks Are Moving the Most Today: Illumina, Roku, Uber, Broadcom, and More -- Barrons.com

9 Nov 2023, 09:39 UTC

Earnings

These Stocks Are Moving the Most Today: Disney, Arm, Applovin, Affirm, Topgolf Callaway, and More -- Barrons.com

Peer Comparison

Price change

Illumina Inc Forecast

Price Target

By TipRanks

5.09% upside

12 Months Forecast

Average 157.38 USD  5.09%

High 252 USD

Low 105 USD

Based on 16 Wall Street analysts offering 12 month price targets forIllumina Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

16 ratings

10

Buy

5

Hold

1

Sell

Technical Score

By Trading Central

142.9 / N/ASupport & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

122 / 390 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Illumina Inc

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.